Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina

Stock Information for Yield10 Bioscience Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Yield10 Bioscience Inc.

Yield10 Bioscience Announces Second Quarter 2024 Financial Results
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets
Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label
Yield10 Bioscience Announces First Quarter 2024 Financial Results
Yield10 Bioscience Announces Delisting from Nasdaq
Yield10 Bioscience Announces 1-for-24 Reverse Stock Split
Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.